Responsible for growing new Dermatology topical agent through multi-channel marketing. Leading long term brand planning through large cross functional team. Developed digital solution to target the ideal patient and pair them with key prescribers. Launched new business model selling outside of retail pharmacy channel.

Responsible for business development and account management including contract negotiations for two large Consumer Packaged Goods accounts worth $7 million in revenue. Directed team of 7 analysts across numerous client needs, brands and priorities to grow established accounts at over 15% year over year exceeding targets in 2012 and 2013.

Directed digital marketing projects in Canada, US and Europe.

Lead Anti-Infective franchise consisting of 3 products, and over $50M sales by repositioning 10 year old product to be exciting to physicians again. Created digital strategies to complement traditional sales force efforts and managed complex contracting strategy with hospitals across Canada.

Managed 11 sales reps across Canada, with no voluntary turnover. Team sales call volume was at 121% to target for 2009 and increased new patient starts by 39% year over year.

Responsible for lifecycle management of a biologic for Multiple Sclerosis. Launched thinnest needle on the market and two auto-injectors.Restructured and rebranded patient support program resulting in enhanced patient experience and significant reduction in patient complaints. Developed, piloted and launched patient health record for a mobile device being the first Multiple Sclerosis app in Canada, later adopted globally resulting in winning prestigious Bayer Gold Cross award for strategic thinking.

Fertility: Creation of extensive consumer media campaign to drive patients into fertility clinics including: Consumer website, internet advertising, magazine, posters, brochures. Negotiated contracts with individual clinics for segmented preferential pricing and structured deals for exclusive use of Organon products where possible. Antidepressant:Re-launched new formulation Remeron RD Antidepressant with new positioning, messaging, pricing and targeting resulting in over 250% growth in 2005. Frequent presentations to sales team and senior management. Represented Canada on global brand team for launch of new Antipsychotic to be co-promoted with Pfizer.

Managed prestigious Toronto Hospitals territory, calling on leading CNS specialists including world wide key opinion leaders and researchers. Above forecast on key products for 2003 (Reminyl 110%, Risperdal 102%, Duragesic 117%), 2002 (Reminyl 111%, Risperdal 102%). Highest call average of all Eldercare representatives in Canada for 2 straight years. Guest in house trainer for Representatives on key marketing messages and selected as Field Sales Trainer in June 2004 for new and developing representatives.